Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer.
Jörg TamihardjaStefan WeickPaul LutyjMarcus ZimmermannKlaus BratengeierMichael FlentjeBülent PolatPublished in: Acta oncologica (Stockholm, Sweden) (2022)
Co-60 brachytherapy sources are an effective alternative to Ir-192 in combined prostate HDR-BT boost + EBRT.